Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

Eli Lilly and Company's Zepbound demonstrated superior weight reduction compared to Novo Nordisk's Wegovy in a 72-week ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

Weight loss injections may hold surprising potential in preventing cancer — beyond simply helping patients lose weight, according to new research presented at the European Congress on Obesity.